Protein kinase C (PKC) isozyme-specific substrates and their design

Biotechnology Advances

Volumn 30, Issue 6, 2012, Pages 1662-1672

  Kang, Jeong Hun ^a   Toita, Riki ^b,c   Kim, Chan Woo ^b   Katayama, Yoshiki ^b  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Cellular signal; Enzyme; Isozymes; Peptide substrate; Phosphorylation; Protein kinase C

Indexed keywords

CELLULAR SIGNALS; COMPUTATIONAL PREDICTIONS; CONSENSUS SEQUENCE; GROWTH FACTOR; INTRACELLULAR SIGNALING PATHWAYS; ISOZYMES; PEPTIDE SUBSTRATES; PHOSPHORYLATION SITES; PROTEIN KINASE C; SIGNAL TRANSDUCTION PATHWAYS; SYNTHETIC PEPTIDE; TARGET PROTEINS;

AMINO ACIDS; DESIGN; ENZYMES; ISOENZYMES; PEPTIDES; PHOSPHOLIPIDS; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

SUBSTRATES;

ISOENZYME; PEPTIDE; PROTEIN KINASE C;

ENZYME ACTIVITY; HORMONE; PEPTIDE; PHOSPHOLIPID; PROTEIN; SIGNAL; SUBSTRATE;

AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; ENZYME SPECIFICITY; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PROTEIN ENGINEERING; PROTEIN MOTIF; REVIEW;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; HUMANS; ISOENZYMES; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN ENGINEERING; PROTEIN KINASE C; SUBSTRATE SPECIFICITY;

MURINAE;

EID: 84867705071     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2012.07.004     Document Type: Review

References (223)

1. Abeyweera T.P., Chen X., Rotenberg S. Phosphorylation of α6-tubulin by protein kinase Cα activates motility of human breast cells. J Biol Chem 2009, 284:17648-17656.
2. 1 cells stimulated by thyrotropin-releasing hormone. FEBS J 2007, 274:3270-3285.
3. Alvarez-Moya B., López-Alcalá C., Drosten M., Agell N. K-ras4B phosphorylation at Ser181 is inhibited by calmodulin and modulates K-ras activity and function. Oncogene 2010, 29:5911-5922.
4. Ammendrup-Johnsen I., Thorsen T.S., Gether U., Madsen K.L. Serine 77 in the PDZ domain of PICK1 is a protein kinase Cα phosphorylation site regulated by lipid membrane binding. Biochemistry 2012, 51:586-596.
5. Andrea J.E., Sutherland C., Winter C.K., Walsh M.P. Substrate-dependent activation requirements and kinetic properties of protein kinase C. FEBS Lett 1998, 429:73-77.
6. Aziz M.H., Hafeez B.B., Sand J.M., Pierce D.B., Aziz S.W., Dreckschmidt N.E., et al. Protein kinase Cε mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression, and cell invasion in various human cancer cell lines through integration with MAPK cascade (RAF-1, MEK1/2, and ERK1/2). Oncogene 2010, 29:3100-3109.
7. Barnett M.E., Madgwick D.K., Takemoto D.J. Protein kinase C as a stress sensor. Cell Signal 2007, 19:1820-1829.
8. Basu N.K., Kovarova M., Garza A., Kubota S., Saha T., Mitra P., et al. Phosphorylation of a UDP-glucuronosyltransferase regulates substrate specificity. Proc Natl Acad Sci U S A 2005, 102:6285-6290.
9. Bazzi M.D., Nelsestuen G.L. Autophosphorylation of protein kinase C may require a high order of protein-phospholipid aggregates. J Biol Chem 1992, 267:22891-22896.
10. Beck A., Moeschel K., Deeg M., Häring H.U., Voelter W., Schleicher E.D., et al. Identification of an in vitro insulin receptor substrate-1 phosphorylation by negative-ion-muLC/ES-API-CID-MS hybrid scan technique. J Am Soc Mass Spectrom 2003, 14:401-405.
11. Biswas A.K., Noman N., Sikder A.R. Machine learning approach to predict protein phosphorylation sites by incorporating evolutionary information. BMC Bioinformatics 2010, 11:273.
12. Blackshear P.J. The MARCKS family of cellular protein kinase C substrates. J Biol Chem 1993, 268:1501-1504.
13. Blom N., Gammeltoft S., Brunak S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 1999, 294:1351-1362.
14. Blom N., Sicheritz-Pontén T., Gupta R., Gammeltoft S., Brunak S. Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics 2004, 4:1633-1649.
15. Blume-Jensen P., Wernstedt C., Heldin C.H., Rönnstrand L. Identification of the major phosphorylation sites for protein kinase C in kit/stem cell factor receptor in vitro and in intact cells. J Biol Chem 1995, 270:14192-14200.
16. Borowski P., Schulze zur Wiesch J., Resch K., Feucht H., Laufs R., Schmitz H. Protein kinase C recognizes the protein kinase A-binding motif of nonstructural protein 3 of hepatitis C virus. J Biol Chem 1999, 274:30722-30728.
17. Borowski P., Resch K., Schmitz H., Heiland M. A synthetic peptide derived from the non-structural protein 3 of hepatitis C virus serves as a specific substrate for PKC. Biol Chem 2000, 381:19-27.
18. Bousquet S.M., Monet M., Boulay G. Protein kinase C-dependent phosphorylation of transcient receptor potential canonical 6 (TRPC6) on serine 448 causes channel inhibition. J Biol Chem 2010, 285:40534-40543.
19. Breitkreutz D., Braiman-Wiksman L., Daum N., Denning M.F., Tennenbaum T. Protein kinase C family: on the crossroads of cell signaling in skin and tumor epithelium. J Cancer Res Clin Oncol 2007, 133:793-808.
20. Brinkworth R.I., Breinl R.A., Kobe B. Structural basis and prediction of substrate specificity in protein serine/threonine kinases. Proc Natl Acad Sci U S A 2003, 100:74-79.
21. 2+/calmodulin-dependent protein kinase II inhibitors disrupt AKAP79-dependent PKC signaling to GluA1 AMPA receptors. J Biol Chem 2011, 286:6697-6706.
22. Brzeska H., Lynch T.J., Martin B., Corigliano-Murphy A., Korn E.D. Substrate specificity of Acanthamoeba myosin Ι heavy chain kinase as determined with synthetic peptides. J Biol Chem 1990, 265:16138-16144.
23. Burchfield J.G., Lennard A.J., Narasimhan S., Hughes W.E., Wasinger V.C., Corthals G.L., et al. Akt mediates insulin-stimulated phosphorylation of Ndrg2: evidence for cross-talk with protein kinase C θ. J Biol Chem 2004, 279:18623-18632.
24. Chappell D.S., Patel N.A., Jiang K., Li P., Watson J.E., Byers D.M., et al. Functional involvement of protein kinase CβII and its substrate, myristoylated alanine-rich C-kinase substrate (MARCKS), in insulin-stimulated glucose transport in L6 rat skeletal muscle cells. Diabetologia 2009, 52:901-911.
25. Chen S.J., Klann E., Gower M.C., Powell C.M., Sessoms J.S., Sweatt J.D. Studies with synthetic peptide substrates derived from the neuronal protein neurogranin reveal structural determinants of potency and selectivity for protein kinase C. Biochemistry 1993, 32:1032-1039.
26. Cip1 level by a KLF4 transcription factor-dependent mechanism. J Biol Chem 2011, 286:28772-28782.
27. Chou M.M., Hou W., Johnson J., Graham L.K., Lee M.H., Chen C.S., et al. Regulation of protein kinase C ζ by PI 3-kinase and PDK-1. Curr Biol 1998, 8:1069-1077.
28. Corbit K.C., Trakul N., Eves E.M., Diaz B., Marshall M., Rosner M.R. Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J Biol Chem 2003, 278:13061-13068.
29. Côté G.P., Bukiejko U. Purification and characterization of a myosin heavy chain kinase from Dictyostelium discoideum. J Biol Chem 1987, 262:1065-1072.
30. Dai J., Wang L.S., Wu Y.B., Sheng Q.H., Wu J.R., Shieh C.H., et al. Fully automatic separation and identification of phosphopeptides by continuous pH-gradient anion exchange online coupled with reversed-phase liquid chromatography mass spectrometry. J Proteome Res 2009, 8:133-141.
31. phox and participates in formyl peptide-mediated neutrophil respiratory burst. J Immunol 2001, 166:1206-1213.
32. Danis R.P., Sheetz M.J. Ruboxistaurin: PKC-β inhibition for complications of diabetes. Expert Opin Pharmacother 2009, 10:2913-2925.
33. Davies S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000, 351:95-105.
34. Deak M., Clifton A.D., Lucocq L.M., Alessi D.R. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J 1998, 17:4426-4441.
35. Dekker L.V., McIntyre P., Parker P.J. Altered substrate selectivity of PKC-η pseudosubstrate site mutants. FEBS Lett 1993, 329:129-133.
36. Ding R.Q., Tsao J., Chai H., Mochly-Rosen D., Zhou W. Therapeutic potential for protein kinase C inhibitor in vascular restenosis. J Cardiovasc Pharmacol Ther 2011, 16:160-167.
37. Dinkel H., Chica C., Via A., Gould C.M., Jensen L.J., Gibson T.J., et al. Phospho.ELM: a database of phosphorylation sites-update 2011. Nucleic Acids Res 2011, 39:D261-D267.
38. Dobransky T., Doherty-Kirby A., Kim A.R., Brewer D., Lajoie G., Rylett R.J. Protein kinase C isoforms differentially phosphorylate human choline acetyltransferase regulating its catalytic activity. J Biol Chem 2004, 279:52059-52068.
39. Doller A., Huwiler A., Müller, Radeke H.H., Pfeilschifter J., Eberhardt W. Protein kinase Cα-dependent phosphorylation of the mRNA-stabilizing factor HuR: implications for posttranscriptional regulation of cyclooxygenase-2. Mol Biol Cell 2007, 18:2137-2148.
40. Duran A., Diaz-Meco M.T., Moscat J. Essential role of RelA Ser311 phosphorylation by ζPKC in NF-κB transcription activation. EMBO J 2003, 22:3910-3918.
41. Durek P., Schmidt R., Heazlewood J.L., Jones A., MacLean D., Nagel A., et al. PhosPhAt: the Arabidopsis thaliana phosphorylation site database. An update. Nucleic Acids Res 2010, 38:D828-D834.
42. Eggert M., Radomski N., Tripier D., Traub P., Jost E. Identification of phosphorylation sites on murine nuclear lamin C by RT-HPLC and microsequencing. FEBS Lett 1991, 292:205-209.
43. Eggert M., Radomski N., Linder D., Tripier D., Traub P., Jost E. Identification of novel phosphorylation sites in murine A-type lamins. Eur J Biochem 1993, 213:659-671.
44. phox during neutrophil activation. J Biol Chem 1994, 269:23431-23436.
45. Ellis J.J., Kobe B. Predicting protein kinase specificity: predikin update and performance in the DREAM4 challenge. PLoS One 2011, 6:e21169.
46. Francis S.H., Busch J.L., Corbin J.D. cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev 2010, 62:525-563.
47. Frasch S.C., Henson P.M., Kailey J.M., Richter D.A., Janes M.S., Fadok V.A., et al. Regulation of phospholipid scramblase activity during apoptosis and cell activation by protein kinase Cδ. J Biol Chem 2000, 275:23065-23073.
48. Freeley M., Kelleher D., Long A. Regulation of protein kinase C function by phosphorylation on conserved and non-conserved sites. Cell Signal 2011, 23:753-762.
49. Fujii K., Zhu G., Liu Y., Hallam J., Chen L., Herrero J., et al. Kinase peptide specificity: improved determination and relevance to protein phosphorylation. Proc Natl Acad Sci U S A 2004, 101:13744-13749.
50. Gilar M., Yu Y.Q., Ahn J., Fournier J., Gebler J.C. Mixed-mode chromatography for fractionation of peptides, phosphopeptides, and sialylated glycopeptides. J Chromatogr A 2008, 1191:162-170.
51. Gineste R., Sirvent A., Paumelle R., Helleboid S., Aquillna A., Darteil R., et al. Phosphorylation of farnesoid X receptor by protein kinase C promotes its transcriptional activity. Mol Endocrinol 2008, 22:2433-2447.
52. Gnad F., Gunawardena J., Mann M. PHOSIDA 2011: the posttranslational modification database. Nucleic Acids Res 2011, 39:D253-D260.
53. Gould K.L., Woodgett J.R., Isacke C.M., Hunter T. The protein-tyrosine kinase substrate p39 is also a substrate for protein kinase C in vitro and in vivo. Mol Cell Biol 1986, 6:2738-2744.
54. Graff J.M., Rajan R.R., Randall R.R., Nairn A.C., Blackshear P.J. Protein kinase C substrate and inhibitor characteristics of peptides derived from the myristoylated alanine-rich C kinase substrate (MARCKS) protein phosphorylation site domain. J Biol Chem 1991, 266:14390-14398.
55. Greene N.M., Williams D.S., Newton A.C. Identification of protein kinase C phosphorylation sites on bovine rhodopsin. J Biol Chem 1997, 272:10341-10344.
56. Greene M.W., Morrice N., Garofalo R.S., Roth R.A. Modulation of human insulin receptor substrate-1 tyrosine phosphorylation by protein kinase Cδ. Biochem J 2004, 378:105-116.
57. Greene M.W., Ruhoff M.S., Roth R.A., Kim J., Quon M.J., Krause J.A. PKCδ-mediated IRS-1 Ser24 phosphorylation negatively regulates IRS-1 function. Biochem Biophys Res Commun 2006, 349:976-986.
58. Guo D., Mant C.T., Taneja A.K., Parker J.M.R., Rodges R.S. Prediction of peptide retention times in reversed-phase high-performance liquid chromatography I. Determination of retention coefficients of amino acid residues of model synthetic peptides. J Chromatogr A 1986, 359:499-518.
59. Gupta A., Blondel D., Choudhary S., Banerjee A.K. The phosphoprotein of rabies virus is phosphorylated by a unique cellular protein kinase and specific isomers of protein kinase C. J Virol 2000, 74:91-98.
60. Gwak J., Cho M., Gong S.J., Won J., Kim D.E., Kim E.Y., et al. Protein-kinase-C-mediated β-catenin phosphorylation negatively regulates the Wnt/β-catenin pathway. J Cell Sci 2006, 119:4702-4709.
61. Hannun Y.A., Bell R.M. Rat brain protein kinase C: kinetic analysis of substrate dependence, allosteric, regulation, and autophosphorylation. J Biol Chem 1990, 265:2962-2972.
62. Kip1 mRNA through suppression of JNK/c-Jun signaling under stress conditions. Cell Death Dis 2011, 2:e157.
63. Heasley L.E., Johnson G.L. Regulation kinase C by nerve growth factor, epidermal growth factor, and phorbol ester in PC12 pheochromocytoma cells. J Biol Chem 1989, 264:8646-8652.
64. Herget T., Oehrlein S.A., Pappin D.J.C., Rozengurt E., Parker P.J. The myristoylated alanine-rich C-kinase substrate (MARCKS) is sequentially phosphorylated by conventional, novel and atypical isotypes of protein kinase C. Eur J Biochem 1995, 233:448-457.
65. Hjerrild M., Gammeltoft S. Phosphoproteomics toolbox: computational biology, protein chemistry and mass spectrometry. FEBS Lett 2006, 580:4764-4770.
66. Hocevar B.A., Burns D.J., Fields A.P. Identification of protein kinase C (PKC) phosphorylation sites on human lamin B. J Biol Chem 1993, 268:7545-7552.
67. Hornbeck P.V., Chabra I., Kornhauser J.M., Skrzypek E., Zhang B. PhosphoSite: a bioinformatics resource dedicated to physiological protein phosphorylation. Proteomics 2004, 4:1551-1561.
68. House C., Kemp B.E. Protein kinase C contains a pseudosubstrate prototype in its regulatory domain. Science 1987, 238:1726-1728.
69. Hsieh J.C., Jurutka P.W., Galligan M.A., Terpening C.M., Haussler C.A., Samuels D.S., et al. Human vitamin D receptor is selectively phosphorylated by protein kinase C on serine 51, a residue crucial to its trans-activation function. Proc Natl Acad Sci U S A 1991, 88:9315-9319.
70. Huang W., Mishra V., Batra S., Dillon I., Mehta K.D. Phorbol ester promotes histone H3-Ser10 phosphorylation at the LDL receptor promoter in a protein kinase C-dependent manner. J Lipid Res 2004, 45:1519-1527.
71. 2+/calmodulin-dependent protein kinase II. Biochem J 2002, 364:593-611.
72. Hughes A.S., Averill S., King V.R., Molander C., Shortland P.J. Neurochemical characterization of neuronal populations expression protein kinase C gamma isoform in the spinal cord and gracile nucleus of the rat. Neuroscience 2008, 153:507-517.
73. Hunter T., Ling N., Cooper J.A. Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane. Nature 1984, 311:480-483.
74. Huntley C.C., De B.P., Murray N.R., Fields A.P., Banerjee A.K. Human parainfluenza virus type 3 phosphoprotein: identification of serine 333 as the major site for PKCζ phosphorylation. Virology 1995, 211:561-567.
75. Ikenoya M., Hidaka H., Hosoya T., Suzuki M., Yamamoto N., Sasaki Y. Inhibition of Rho-kinase-induced myristoylated alanine-rich C kinase substrate (MARCKS) phosphorylation in human neuronal cells by H-1152, a novel and specific Rho-kinase inhibitor. J Neurochem 2002, 81:9-16.
76. Imai S., Kai M., Yamada K., Kanoh H., Sakane F. The plasma membrane translocation of diacylglycerol kinase δ1 is negatively regulated by conventional protein kinase C-dependent phosphorylation at Ser-22 and Ser-26 within the pleckstrin homology domain. Biochem J 2004, 382:957-966.
77. Jain N., Zhang T., Kee W.H., Li W., Cao X. Protein kinase C δ associates with and phosphorylates Stat3 in an interleukin-6-dependent manner. J Biol Chem 1999, 274:24392-34400.
78. Jenkins M.A., Traynelis S.F. PKC phosphorylates GluA1-Ser831 to enhance AMPA receptor conductance. Channels 2012, 6:60-64.
79. Jideama N.M., Noland T.A., Raynor R.L., Blobe G.C., Fabbro D., Kazanietz M.G., et al. Phosphorylation specificities of protein kinase C isozymes for bovine cardiac troponin I and troponin T and sites within these proteins and regulation of myofilament properties. J Biol Chem 1996, 271:23277-23283.
80. Kajimoto T., Sawamura S., Tohama Y., Mori Y., Newton A.C. Protein kinase C δ-specific activity reporter reveals agonist-evoked nuclear activity controlled by Scr family of kinases. J Biol Chem 2010, 285:41896-41910.
81. Kang J.H., Jiang Y., Toita R., Oishi J., Kawamura K., Han A., et al. Phosphorylation of Rho-associated kinase (Rho-kinase/ROCK/ROK) substrates by protein kinase A and C. Biochimie 2007, 89:39-47.
82. Kang J.H., Asai D., Kim J.H., Mori T., Toita R., Tomiyama T., et al. Design of polymeric carriers for cancer-specific gene targeting: utilization of abnormal protein kinase Cα activation in cancer cells. J Am Chem Soc 2008, 130:14906-14907.
83. Kang J.H., Asai D., Yamada S., Toita R., Oishi J., Mori T., et al. A short peptide is a protein kinase C (PKC)α-specific substrate. Proteomics 2008, 8:2006-2011.
84. Kang J.H., Asai D., Toita R., Kitazaki H., Katayama Y. Plasma protein kinase C (PKC)α as a biomarker for the diagnosis of cancers. Carcinogenesis 2009, 30:1927-1931.
85. Kang J.H., Asami Y., Murata M., Kitazaki H., Sadanaga N., Tokunaga E., et al. Gold nanoparticles-based colorimetric assay for cancer diagnosis. Biosens Bioelectron 2010, 25:1869-1874.
86. Kang J.H., Oishi J., Kim J.H., Ijuin M., Toita R., Jun B., et al. Hepatoma-targeted gene delivery using a tumor cell-specific gene regulation system combined with a human liver cell-specific bionanocapsule. Nanomedicine 2010, 6:583-589.
87. Kang J.H., Asai D., Tsuchiya A., Mori T., Niidome T., Katayama Y. Peptide substrates for Rho-associated kinase 2 (Rho-kinase 2/ROCK2). PLoS One 2011, 6:e22699.
88. Kemp B.E., Graves D.J., Benjamini E., Krebs E.G. Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase. J Biol Chem 1977, 252:4888-4894.
89. Kemp B.E., Pearson R.B., House C. Role of basic residues in the phosphorylation of synthetic peptides by myosin light chain kinase. Proc Natl Acad Sci U S A 1983, 80:7471-7475.
90. Keshava Prasad T.S., Goel R., Kandasamy K., Keerthikumar S., Kumar S., Mathivanan S., et al. Human Protein Reference Database-2009 update. Nucleic Acids Res 2009, 37:D767-D772.
91. Kielbassa K., Müller H.J., Meyer H.E., Marks F., Gschwendt M. Protein kinase Cδ-specific phosphorylation of the elongation factor eEF-α and an eEF-1 α peptide at threonine 431. J Biol Chem 1995, 270:6156-6162.
92. Kim J.H., Lee J., Oh B., Kimm K., Koh I. Prediction of phosphorylation sites using SVMs. Bioinformatics 2004, 20:3179-3184.
93. Kochs G., Hummel R., Meyer D., Hug H., Marmé D., Sarre T.F. Activation and substrate specificity of the human protein kinase C α and ζ isoenzymes. Eur J Biochem 1993, 216:597-606.
94. Koga H., Toita R., Mori T., Tomiyama T., Kang J.H., Niidome T., et al. Fluorescent nanoparticles consisting of lipopeptides and fluorescein-modified polyanions for monitoring of protein kinase activity. Bioconjugate Chem 2011, 22:1526-1534.
95. Koivunen P., Hirsilä M., Kivirikko K.I., Myllyharju J. The length of peptide substrates has a marked effect on hydroxylation by the hypoxia-inducible factor prolyl 4-hydroxylases. J Biol Chem 2006, 281:28712-28720.
96. Kolch W., Heidecker G., Kochs G., Hummel R., Vahidi H., Mischak H., et al. Protein kinase Cα activates RAF-1 by direct phosphorylation. Nature 1993, 364:249-252.
97. Konopatskaya O., Poole A.W. Protein kinase Cα: disease regulator and therapeutic target. Trends Pharmacol Sci 2010, 31:8-14.
98. Kosako H., Nagano K. Quantitative phosphoproteomics strategies for understanding protein kinase-mediated signal transduction pathways. Expert Rev Proteomics 2011, 8:81-94.
99. Krasel C., Dammeier S., Winstel R., Brockmann J., Mischak H., Lohse M.J. Phosphorylation of GRK2 by protein kinase C abolishes its inhibition by calmodulin. J Biol Chem 2001, 276:1911-1915.
100. Kreegipuu A., Blom N., Brunak S., Järv J. Statistical analysis of protein kinase specificity determinants. FEBS Lett 1998, 430:45-50.
101. Kroviarski Y., Debbabi M., Bachoual R., Périanin A., Gougerot-Pocidalo M.A., El Benna J., et al. Phosphorylation of NADPH oxidase activator 1 (NOXA1) on serine 282 by MAP kinases and on serine172 by protein kinase C and protein kinase A prevents NOX1 hyperactivation. FASEB J 2010, 24:2077-2092.
102. Ku N.O., Omary B. Identification of the major physiologic phosphorylation site of human keratin 18: potential kinases and a role in filament reorganization. J Cell Biol 1994, 127:161-171.
103. Kumar N., Mohanty D. MODPROPEP: a program for knowledge-based modeling of protein-peptide complexes. Nucleic Acid Res 2007, 35:W549-W555.
104. Larsson C. Protein kinase C and the regulation of the actin cytoskeleton. Cell Signal 2006, 18:276-284.
105. Le Good J.A., Ziegler W.H., Parekh D.B., Alessi D.R., Cohen P., Parker P.J. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 1998, 281:2042-2045.
106. 2+/calmodulin-dependent protein kinase Ιa. Proc Natl Acad Sci U S A 1994, 91:6413-6417.
107. Leighton I.A., Dalby K.N., Caudwell F.B., Cohen P.T.W., Cohen P. Comparison of the specificities of p70 S6 kinase and MAPKAP kinase-1 identifies a relatively specific substrate for p70 S6 kinases: the N-terminal kinase domain of MAPKAP kinase-1 is essential for peptide phosphorylation. FEBS Lett 1995, 375:289-293.
108. 2+/phospholipid-dependent protein kinase. Eur J Biochem 1989, 179:415-422.
109. Letschka T., Kollmann V., Pfeifhofer-Obermair C., Lutz-Nicoladoni C., Obermair G.J., Fresser F., et al. PKC-θ selectively controls the adhesion-stimulating molecule Rap1. Blood 2008, 112:4617-4627.
110. Lévay M., Settleman J., Ligeti E. Regulation of the substrate preference of p190RhoGAP by protein kinase C-mediated phosphorylation of a phospholipid binding site. Biochemistry 2009, 48:8615-8623.
111. Leventhal P.S., Bertics P.J. Activation of protein kinase C by selective binding of arginine-rich polypeptides. J Biol Chem 1993, 268:13906-13913.
112. 1101. J Biol Chem 2004, 279:45304-45307.
113. Liberman Z., Plotkin B., Tennenbaum T., Eldar-Finkelman H. Coordinated phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 and protein kinase in the diabetic fat tissue. Am J Physiol Endocrinol Metab 2008, 294:E1169-E1177.
114. Lim K.B., Kassel D.B. Phosphopeptides enrichment using on-line two-dimensional strong cation exchange followed by reversed-phase liquid chromatography/mass spectrometry. Anal Biochem 2006, 354:213-219.
115. Liu Z., Liu X., Nakayama K.I., Nakayama K., Ye K. Protein kinase C-δ phosphorylates Ebp1 and prevents its proteolytic degradation, enhancing cell survival. J Neurochem 2007, 100:1278-1288.
116. Loyet K.M., Stults J.T., Arnott D. Mass spectrometric contributions to the practice of phosphorylation site mapping through 2003. Mol Cell Proteomics 2005, 4:235-245.
117. Ludowyke R.I., Elgundi Z., Kranenburg T., Stehn J.R., Schmitz-Peiffer C., Hughes W.E., et al. Phosphorylation of nonmuscle myosin heavy chain IIA on Ser 1917 is mediated by protein kinase CβII and coincides with the onset of stimulated degranulation of RBL-2H3 mast cells. J Immunol 2006, 177:1492-1499.
118. Luo W., Yan G., Li L., Wang Z., Liu H., Zhou S., et al. Epstein-Barr virus latent membrane protein 1 mediates serine 25 phosphorylation and nuclear entry of annexin A2 via PI-PLC-PKCα/PKCβ pathway. Mol Carcinog 2008, 47:934-946.
119. Mackay H.J., Twelves C.J. Targeting the protein kinase C family: are we there yet?. Nat Rev Cancer 2007, 7:554-562.
120. Madaro L., Pelle A., Nicoletti C., Crupi A., Marrocco V., Bossi G., et al. PKC theta ablation improves healing in a mouse model of muscular dystrophy. PLoS One 2012, 7:e31515.
121. Maizels E.T., Peters C.A., Kline M., Cutler R.E., Shanmugam M., Hunzicker-Dunn M. Heat-shock protein-25/27 phosphorylation by the δ isoform of protein kinase C. Biochem J 1998, 332:703-712.
122. q-mediated activation of GRK2 by mechanical stretch in cardiac myocytes. J Biol Chem 2010, 285:13748-13760.
123. Mamidipudi W., Lin C., Seibenhener M.L., Wooten M.W. Regulation of interleukin receptor-associated kinase (IRAK) phosphorylation and signaling by iota protein kinase C. J Biol Chem 2004, 279:4161-4165.
124. Mandadi S., Tominaga T., Numazaki M., Murayama N., Saito N., Armati P.J., et al. Increased sensitivity of desensitized TRPV1 by PMA occurs through PKCε-mediated phosphorylation at S800. Pain 2006, 123:106-116.
125. Manning B.D., Cantley L.C. Akt/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274.
126. Mant C.T., Kovacs J.M., Kim H.M., Pollock D.D., Hodges R.S. Intrinsic amino acid side-chain hydrophilicity/hydrophobicity coefficients determined by reversed-phase high-performance liquid chromatography of model peptides: comparison with other hydrophilicity/hydrophobicity scales. Biopolymers 2009, 92:573-595.
127. Marais R.M., Parker P.J. Purification and characterization of bovine brain protein kinase C isotypes α, β and γ. Eur J Biochem 1989, 182:129-137.
128. Martelli A.M., Faenza I., Billi A.M., Falá F., Cocco L., Manzoli L. Nuclear protein kinase C isoforms: key players in multiple cell functions?. Histol Histopathol 2003, 18:1301-1312.
129. Martelli A.M., Evangelisti C., Nyakern M., Manzoli L. Nuclear protein kinase C. Biochim Biophys Acta 2006, 1761:542-551.
130. Martiny-Baron G., Fabbro D. Classical PKC isoforms in cancer. Pharmacol Res 2007, 55:477-486.
131. 2+- and substrate-binding sites on protein kinase Cα as determined by nuclear magnetic resonance spectroscopy. Biochemistry 1992, 31:7714-7721.
132. McQueen P., Krokhin O. Optimal selection of 2D reversed-phase-reversed-phase HPLC separation techniques in bottom-up proteomics. Expert Rev Proteomics 2012, 9:125-128.
133. Messerschmidt A., Macieira S., Velarde M., Bädeker M., Benda C., Jestel A., et al. Crystal structure of the catalytic domain of human atypical protein kinase C-iota reveals interaction mode of phosphorylation site in turn motif. J Mol Biol 2005, 352:918-931.
134. Messina G., Biressi S., Monteverde S., Magli A., Cassano M., Perani L., et al. Nfix regulates fetal-specific transcription in developing skeletal muscle. Cell 2010, 140:554-566.
135. Metzger E., Imhof A., Patel D., Kahl P., Hoffmeyer K., Friedrichs N., et al. Phosphorylation of histone H3T6 by PKCβI controls demethylation at histone H3K4. Nature 2010, 464:792-796.
136. Michel H., Bennett J. Use of synthetic peptides to study the substrate specificity of a thylakoid protein kinase. FEBS Lett 1989, 254:167-170.
137. Michell B.J., Chen Z., Tiganis T., Stapleton D., Katsis, Power D.A., et al. Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem 2001, 276:17625-17628.
138. 318 in insulin receptor substrate-1 (IRS-1) attenuates the interaction with the insulin receptor and the tyrosine phosphorylation of IRS-1. J Biol Chem 2004, 279:25157-25163.
139. Mohammad G., Kowluru R.A. The role of Raf-1 kinase in diabetic retinopathy. Expert Opin Ther Targets 2011, 15:357-364.
140. Morfini G., Pigino G., Opalach K., Serulle Y., Moreira J.E., Sugimori M., et al. 1-methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C. Proc Natl Acad Sci U S A 2007, 104:2442-2447.
141. Moyers J.S., Zhu J., Kahn C.R. Effects of phosphorylation on function of the Rad GTPase. Biochem J 1998, 333:609-614.
142. Municio M., Lozano J., Sánchez P., Moscat J., Diaz-Meco M. Identification of heterogeneous ribonucleoprotein A1 as a novel substrate for protein kinase C ζ. J Biol Chem 1995, 270:15884-15891.
143. Murphy C.T., Westwick J. Selective inhibition of protein kinase C: effect on platelet-activating-factor-induced platelet functional responses. Biochem J 1992, 283:159-164.
144. II protein kinase C-selective nuclear membrane activation factor in human leukemia cells. J Biol Chem 1994, 269:21385-21390.
145. Nagumo H., Ikenoya M., Sakurada K., Furuya K., Ikuhara T., Hiraoka H., et al. Rho-associated kinase phosphorylates MARCKS in human neuronal cells. Biochem Biophys Res Commun 2001, 280:605-609.
146. Nishikawa K., Toker A., Johannes F.J., Songyang Z., Cantley L.C. Determination of the specific substrate sequence motifs of protein kinase C isozymes. J Biol Chem 1997, 272:952-960.
147. O'Neill T., Giarratani L., Chen P., Iyer L., Lee C.H., Bobiak M., et al. Determination of substrate motifs for human Chk1 and hCds1/Chk2 by the oriented peptide library approach. J Biol Chem 2002, 277:16102-16115.
148. Obenauer J.C., Cantley L.C., Yaffe M.B. Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res 2003, 31:3635-3641.
149. Olivier A.R., Parker P.J. Expression and characterization of protein kinase C-δ. Eur J Biochem 1991, 200:805-810.
150. Ozaki H., Ishii K., Arai H., Horiuchi H., Kawamoto T., Suzuki H., et al. Junctional adhesion molecule (JAM) is phosphorylated by protein kinase C upon platelet activation. Biochem Biophys Res Commun 2000, 276:873-878.
151. Pearson R.B., Kemp B.E. Protein kinase phosphorylation site sequences and consensus specificity motifs: Tabulations. Protein phosphorylation 1998, 65-83. Academic Press, San Diego. B.M. Sefton, T. Hunter (Eds.).
152. Phan D., Stratton M.S., Huynh Q.K., McKinsey T.A. A novel protein kinase C target site in protein kinase D is phosphorylated in response to signals for cardiac hypertrophy. Biochem Biophys Res Commun 2011, 411:335-341.
153. 53 is a novel substrate for protein kinase C βI. Mol Cell Proteomics 2010, 9:2719-2728.
154. Pollock V.V., Pastoor T.E., Wecker L. Cyclic AMP-dependent protein kinase (PKA) phosphorylates Ser362 and 467 and protein kinase C phosphorylates Ser550 within the M3/M4 cytoplasmic domain of human nicotinic receptor α4 subunits. J Neurochem 2007, 103:456-466.
155. Powell K.A., Valova V.A., Malladi C.S., Jensen O.N., Larsen M.R., Robinson P.J. Phosphorylation of dynamin I on Ser-795 by protein kinase C blocks its association with phospholipids. J Biol Chem 2000, 275:11610-11617.
156. Que S., Wang Y., Chen P., Tang Y.R., Zhang Z., He H. Evaluation of protein phosphorylation site predictors. Protein Pept Lett 2010, 17:64-69.
157. Rabinovitz I., Tsomo L., Mercurio A.M. Protein kinase C-α phosphorylation of specific serines in the connecting segment of the β4 integrin regulates the dynamics of type II hemidesmosomes. Mol Cell Biol 2004, 24:4351-4360.
158. Ren J., Datta R., Shioya H., Li Y., Oki E., Biedermann V., et al. p73β is regulated by protein kinase Cδ catalytic fragment generated in the apoptotic response to DNA damage. J Biol Chem 2002, 277:33758-33765.
159. Reyland M.E. Protein kinase C isoforms: multi-functional regulators of cell life and death. Front Biosci 2009, 14:2386-2399.
160. Rosse C., Linch M., Kermorgant S., Cameron A.J., Boeckeler K., Parker P.J. PKC and the control of localized signal dynamics. Nat Rev Mol Cell Biol 2010, 11:103-112.
161. Rybin V.O., Sabri A., Short J., Braz J.C., Molkentin J.D., Steinberg S.F. Cross-regulation of novel protein kinase C (PKC) isoform function in cardiomyocytes. J Biol Chem 2003, 278:14555-14564.
162. Ryu J., Hah J.S., Park J.S., Lee W., Rampal A.L., Jung C.Y. Protein kinase C-ζ phosphorylates insulin-responsive aminopeptidase in vitro at Ser-80 and Ser-91. Arch Biochem Biophys 2002, 403:71-82.
163. 2+/phospholipid-dependent protein kinase and its protease-activated form. Eur J Biochem 1987, 168:669-677.
164. Salih E. Phosphoproteomics by mass spectrometry and classical protein chemistry approaches. Mass Spectrom Rev 2005, 24:828-846.
165. Schaap D., Parker P.J., Bristol A., Kriz R., Knopf J. Unique substrate specificity and regulatory properties of PKC-ε: a rationale for diversity. FEBS Lett 1989, 243:351-357.
166. Scheid M.P., Woodgett J.R. PKB/AKT: functional insights from genetic models. Nat Rev Mol Cell Biol 2001, 2:760-768.
167. Schwemmle M., De B., Shi L., Banerjee A., Lipkin I. Borna disease virus P-protein is phosphorylated by protein kinase Cε and casein kinase II. J Biol Chem 1997, 272:21818-21823.
168. Scott M.T., Ingram A., Ball K.L. PDK 1-dependent activation of atypical PKC leads to degradation of the p21 tumour modifier protein. EMBO J 2002, 21:6771-6780.
169. Seo G.J., Kim S.E., Lee Y.M., Lee J.W., Lee J.R., Hahn M.J., et al. Determination of substrate specificity and putative substrates of Chk2 kinase. Biochem Biophys Res Commun 2003, 304:339-343.
170. Serulle Y., Morfini G., Pigino G., Moreira J.E., Sugimori M., Brady S.T., et al. 1-Methyl-4-phenylpyridinium induces synaptic dysfunction through a pathway involving caspase and PKCδ enzymatic activities. Proc Natl Acad Sci U S A 2007, 104:2437-2441.
171. Shabb J.B. Physiological substrates of cAMP-dependent protein kinase. Chem Rev 2001, 101:2381-2411.
172. Shang L., Kwon Y.G., Nandy S., Lawrence D.S., Edelman A.M. Catalytic and regulatory domains of doublecortin kinase-1. Biochemistry 2003, 42:2185-2194.
173. Song P., Kaczmarek L.K. Modulation of Kv3.1b potassium channel phosphorylation in auditory neurons by conventional and novel protein kinase C isozymes. J Biol Chem 2006, 281:15582-15591.
174. Song C., Ye M., Han G., Jiang X., Wang F., Yu Z., et al. Reversed-phase-reversed-phase liquid chromatography approach with high orthogonality for multidimensional separation of phosphopeptides. Anal Chem 2010, 82:53-56.
175. Songyang Z., Blechner S., Hoagland N., Hoekstra M.F., Piwnica-Worms H., Cantley L.C. Use of an oriented peptide library to determine the optimal substrates of protein kinases. Curr Biol 1994, 4:973-982.
176. Sonnenburg E.D., Gao T., Newton A.C. The phosphoinositide-dependent kinase, PDK-1, phosphorylates conventional protein kinase C isozymes by a mechanism that is independent of phosphoinositide 3-kinase. J Biol Chem 2001, 276:45289-45297.
177. Souvignet C., Chambaz E.M. Phospholipid independent phosphorylation of protamine by protein kinase C: effects of polyanions. Cell Signal 1990, 2:171-176.
178. Srisakuldee W., Jeyaraman M.M., Nickel B.E., Tanguy S., Jiang Z.S., Kardami E. Phosphorylation of connexin-43 at serine 262 promotes a cardiac injury-resistant state. Cardiovasc Res 2009, 83:672-681.
179. Steinberg S.F. Structural basis of protein kinase C isoform function. Physiol Rev 2008, 88:1341-1378.
180. Stokoe D., Caudwell B., Cohen P.T.W., Cohen P. The substrate specificity and structure of mitogen-activated protein (MAP) kinase-activated protein kinae-2. Biochem J 1993, 296:843-849.
181. Storz P., Döppler H., Toker A. Protein kinase Cδ selectively regulates protein kinase D-dependent activation of NF-κB in oxidative stress signaling. Mol Cell Biol 2004, 24:2614-2626.
182. Suzuki A., Hirata M., Kamimura K., Maniwa R., Yamanaka T., Mizuno K., et al. aPKC acts upstream of Par-1b in both the establishment and maintenance of mammalian epithelial polarity. Curr Biol 2004, 14:1425-1435.
183. Suzuki T., Elias B.C., Seth A., Shen L., Turner J.R., Giorgianni F., et al. PKCη regulates occluding phosphorylation and epithelial tight junction integrity. Proc Natl Acad Sci U S A 2009, 106:61-66.
184. Tanabe A., Kamisuki Y., Hidaka H., Suzuki M., Negishi M., Takuwa Y. PKC phosphorylates MARKCS Ser159 not only directly but also through RhoA/ROCK. Biochem Biophys Res Commun 2006, 345:156-161.
185. Taniguchi H., Manenti S., Suzuki M., Titani K. Myristoylated alanine-rich C kinase substrate (MARCKS), a major protein kinase C substrate, is an in vivo substrate of proline-directed protein kinase(s). A mass spectroscopic analysis of the post-translational modifications. J Biol Chem 1994, 269:18299-18302.
186. Thimmaiah K.N., Easton J.B., Houghton P.J. Protection from rapamycin-induced apoptosis by insulin-like growth factor-1 is partially dependent on protein kinase C signaling. Cancer Res 2010, 70:2000-2009.
187. Toita R., Kang J.H., Kim J.H., Tomiyama T., Mori T., Niidome T., et al. Protein kinase Cα-specific peptide substrate graft-type copolymer for cancer cell-specific gene regulation systems. J Control Release 2009, 139:133-139.
188. Tomiyama T., Kang J.H., Toita R., Niidome T., Katayama Y. Protein kinase Cα polymeric carrier: its application for gene delivery into human cancers. Cancer Sci 2009, 100:1532-1536.
189. Tomiyama T., Toita R., Kang J.H., Asai D., Shiosaki S., et al. Tumor therapy by gene regulation system responding to cellular signal. J Control Release 2010, 148:101-105.
190. Trost B., Kusalik A. Computational prediction of eukaryotic phosphorylation sites. Bioinformatics 2011, 27:2927-2935.
191. Tuazon P.T., Spanos W.C., Gump E.L., Monnig C.A., Traugh J.A. Determinants for substrate phosphorylation by p21-activated protein kinase (γ-PAK). Biochemistry 1997, 36:16059-16064.
192. 2+-dependent protein kinase as probed with synthetic peptide fragments of the bovine myelin basic protein. J Biol Chem 1985, 260:11503-11507.
193. Valovka T., Verdier F., Cramer R., Zhyvoloup A., Fenton T., Rebholz H., et al. Protein kinase C phosphorylates ribosomal protein S6 kinase βII and regulates its subcellular localization. Mol Cell Biol 2003, 23:852-863.
194. Vemuri B., Singh S.S. Protein kinase C isozyme-specific phosphorylation of profilin. Cell Signal 2001, 13:433-439.
195. Via A., Diella F., Gibson T.J., Helmer-citterich M. From sequence to structural analysis in protein phosphorylation motifs. Front Biosci 2011, 16:1261-1275.
196. Vinton B.B., Wertz S.L., Jacob J., Steere J., Grisham C.M., Cafiso D.S., et al. Influence of lipid on the structure and phosphorylation of protein kinase C α substrate peptides. Biochem J 1998, 330:1433-1442.
197. Waldron R.T., Rozengurt E. Protein kinase C phosphorylates protein kinase D activation loop Ser744 and Ser748 and releases autoinhibition by the pleckstrin homology domain. J Biol Chem 2003, 278:154-163.
198. Wan J., Kang S., Tang C., Yan J., Ren Y., Liu J., et al. Meta-prediction of phosphorylation sites with weighted voting and restricted grid search parameter selection. Nucleic Acids Res 2008, 36:e22.
199. 532 contributes to palmitate-induced insulin resistance. J Biol Chem 2009, 284:2038-2044.
200. Wang C., Shang Y., Yu J., Zhang M. Substrate recognition mechanism of atypical protein kinase Cs revealed by the structure of PKCι in complex with a substrate peptide for Par-3. Structure 2012, 20:791-801.
201. 357 of rat insulin receptor substrate-1 mediates adverse effects of protein kinase C-δ on insulin action in skeletal muscle cells. J Biol Chem 2008, 283:11226-11233.
202. Watkins J.L., Lewandowski K.T., Meek S.E., Storz P., Toker A., Piwnica-Worms H. Phosphorylation of the Par-1 polarity kinase by protein kinase D regulates 14-3-3 binding and membrane association. Proc Natl Acad Sci U S A 2008, 105:18378-18383.
203. Webb B.L.J., Hirst S.T., Giembycz M.A. Protein kinase C isoenzymes: a review of their structure, regulation and role in regulating airways smooth muscle tone and mitogenesis. Br J Pharmacol 2000, 130:1433-1452.
204. 2+-modulated lipid binding proteins. EMBO J 1987, 6:1599-1604.
205. Welsh G.I., Price N.T., Bladergroen B.A., Bloomberg G., Proud C.G. Identification of novel phosphorylation sites in the β-subunit of translation initiation factor eIF-2. Biochem Biophys Res Commun 1994, 201:1279-1288.
206. 2+-calmodulin-dependent protein kinases IV and II reveals shared and distinctive features. J Biol Chem 1998, 273:3166-3172.
207. Wilkinson S.E., Parker P.L., Nixon J.S. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J 1993, 294:335-337.
208. Wong Y.H., Lee T.Y., Liang H.K., Huang C.M., Wang T.Y., Yang Y.H., et al. KinasePhos 2.0: a web server for identifying protein kinase-specific phosphorylation sites based on sequences and coupling patterns. Nucleic Acids Res 2007, 35:W588-W594.
209. Xiao D.M., Pak J.H., Wang X., Sato T., Huang F.L., Chen H.C., et al. Phosphorylation of HMG-1 by protein kinase C attenuates its binding affinity to the promoter regions of protein kinase C γ and neurogranin/RC3 genes. J Neurochem 2000, 74:392-399.
210. Xue Y., Li A., Wang L., Feng H., Yao X. PPSP: prediction of PK-specific phosphorylation site with Bayesian decision theory. BMC Bioinformatics 2006, 7:163.
211. Yamaguchi Y., Shirai Y., Matsubara T., Sanse K., Kuriyama M., Oshiro N., et al. Phosphorylation and up-regulation of diacylglycerol kinaseγ via its interaction with protein kinase Cγ. J Biol Chem 2006, 281:31627-31637.
212. Yang L., Liu G., Zakharov S.I., Morrow J.P., Rybin V.O., Steinberg S.F., et al. Ser 1928 is a common site for Cav1.2 phosphorylation by protein kinase isoforms. J Biol Chem 2005, 280:207-214.
213. 1c. Biochemistry 2009, 48:6674-6683.
214. Yang F., Shen Y., Camp D.G., Smith R.D. High-pH reversed-phase chromatography with fraction concatenation for 2D proteomic analysis. Expert Rev Proteomics 2012, 9:129-134.
215. Yasuda I., Kishimoto A., Tanaka S., Tominaga M., Sakurai A., Nishizuka Y. A synthetic peptide substrate for selective assay of protein kinase C. Biochem Biophys Res Commun 1990, 166:1220-1227.
216. 46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage. J Biol Chem 2006, 281:5734-5740.
217. Youmell M., Park S.J., Basu S., Price B.D. Regulation of the p53 protein by protein kinase C alpha and protein kinase Cζ. Biochem Biophys Res Commun 1998, 245:514-518.
218. Zarate C.A., Manji H.K. Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder. CNS Drugs 2009, 23:569-582.
219. Zhang Y., Liao M., Dufau M.L. Phosphatidylinositol 3-kinase/protein kinase Cζ-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated depression of transcription of the luteinizing hormone receptor gene. Mol Cell Biol 2006, 26:6748-6761.
220. Zheng Y., Liu H., Coughlin J., Zheng J., Li L., Stone J.C. Phosphorylation of RasGRP3 on threonine 133 provides a mechanistic link between PKC and Ras signaling systems in B cells. Blood 2005, 105:3648-3654.
221. Zhou F.F., Xue Y., Chen G.L., Yao X. GPS: a novel group-based phosphorylation predicting and scoring method. Biochem Biophys Res Commun 2004, 325:1443-1448.
222. Zhu G., Fujii K., Liu Y., Codrea V., Herrero J., Shaw S. A single pair of acidic residues in the kinase major groove mediates strong substrate preference for P-2 or P-5 arginine in the AGC, CAMK, and STE kinase families. J Biol Chem 2005, 280:36372-36379.
223. Ziegler W.H., Tigges U., Zieseniss A., Jockusch B.M. A lipid-regulated docking site on vinculin for protein kinase C. J Biol Chem 2002, 277:7396-7404.